Three month follow up for ACOSOG Z0020, a prospective randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone versus melphalan plus tumor necrosis factor
Publication
, Conference
Cornett, WR; Fraker, DL; Ross, MI; Briele, HA; Boddie, AW; Noyes, RD; Sussman, JJ; McCall, LM; Herndon, JE; Tyler, DS
Published in: ANNALS OF SURGICAL ONCOLOGY
February 1, 2005
Duke Scholars
Published In
ANNALS OF SURGICAL ONCOLOGY
ISSN
1068-9265
Publication Date
February 1, 2005
Volume
12
Issue
2
Start / End Page
S18 / S18
Location
Atlanta, GA
Publisher
SPRINGER
Conference Name
58th Annual Cancer Symposium
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Cornett, W. R., Fraker, D. L., Ross, M. I., Briele, H. A., Boddie, A. W., Noyes, R. D., … Tyler, D. S. (2005). Three month follow up for ACOSOG Z0020, a prospective randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone versus melphalan plus tumor necrosis factor. In ANNALS OF SURGICAL ONCOLOGY (Vol. 12, pp. S18–S18). Atlanta, GA: SPRINGER.
Cornett, W. R., D. L. Fraker, M. I. Ross, H. A. Briele, A. W. Boddie, R. D. Noyes, J. J. Sussman, L. M. McCall, J. E. Herndon, and D. S. Tyler. “Three month follow up for ACOSOG Z0020, a prospective randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone versus melphalan plus tumor necrosis factor.” In ANNALS OF SURGICAL ONCOLOGY, 12:S18–S18. SPRINGER, 2005.
Cornett WR, Fraker DL, Ross MI, Briele HA, Boddie AW, Noyes RD, et al. Three month follow up for ACOSOG Z0020, a prospective randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone versus melphalan plus tumor necrosis factor. In: ANNALS OF SURGICAL ONCOLOGY. SPRINGER; 2005. p. S18–S18.
Cornett, W. R., et al. “Three month follow up for ACOSOG Z0020, a prospective randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone versus melphalan plus tumor necrosis factor.” ANNALS OF SURGICAL ONCOLOGY, vol. 12, no. 2, SPRINGER, 2005, pp. S18–S18.
Cornett WR, Fraker DL, Ross MI, Briele HA, Boddie AW, Noyes RD, Sussman JJ, McCall LM, Herndon JE, Tyler DS. Three month follow up for ACOSOG Z0020, a prospective randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone versus melphalan plus tumor necrosis factor. ANNALS OF SURGICAL ONCOLOGY. SPRINGER; 2005. p. S18–S18.
Published In
ANNALS OF SURGICAL ONCOLOGY
ISSN
1068-9265
Publication Date
February 1, 2005
Volume
12
Issue
2
Start / End Page
S18 / S18
Location
Atlanta, GA
Publisher
SPRINGER
Conference Name
58th Annual Cancer Symposium
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis